2023
The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter Study
Vranic J, Harker P, Stapleton C, Regenhardt R, Dmytriw A, Doron O, Alotaibi N, Leslie-Mazwi T, Gupta R, Berglar I, Tan C, Koch M, Raymond S, Mascitelli J, Patterson T, Seinfeld J, White A, Case D, Roark C, Gandhi C, Al-Mufti F, Cooper J, Matouk C, Sujijantarat N, Devia D, Ocampo-Navia M, Villamizar-Torres D, Puentes J, Patel A. The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter Study. Journal Of Computer Assisted Tomography 2023, 47: 753-758. PMID: 37707405, DOI: 10.1097/rct.0000000000001457.Peer-Reviewed Original ResearchConceptsDual antiplatelet therapyAneurysm occlusion rateAneurysm occlusionDAPT durationThromboembolic complicationsOcclusion rateFlow diversionDuration of DAPTDual antiplatelet therapy durationIntracranial aneurysmsSingle Pipeline Embolization DeviceAntiplatelet therapy durationEndoluminal flow diversionRate of complicationsPrimary outcome measurePipeline Embolization DeviceSignificant differencesUnruptured intracranial aneurysmsAspirin monotherapyAntiplatelet therapyIschemic strokeTherapy durationIatrogenic complicationsRetrospective reviewMulticenter study
2017
O-021 Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms
Griessenauer C, Ogilvy C, Adeeb N, Dmytriw A, Foreman P, Shallwani H, Limbucci N, Mangiafico S, Kumar A, Michelozzi C, Krings T, Pereira V, Matouk C, Harrigan M, Shakir H, Siddiqui A, Levy E, Renieri L, Marotta T, Cognard C, Thomas A. O-021 Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms. Journal Of NeuroInterventional Surgery 2017, 9: a13. DOI: 10.1136/neurintsurg-2017-snis.21.Peer-Reviewed Original ResearchPosterior circulation aneurysmsLow complication ratePipeline Embolization DeviceMinor complicationsSaccular aneurysmComplication rateMajor complicationsMulticenter studySubarachnoid hemorrhageOcclusion rateFusiform aneurysmsCommon off-label useLower occlusion rateOff-label useHigh occlusion rateHigh mortality rateClopidogrel respondersConsecutive patientsAcute phasePipeline embolizationRetrospective reviewPED placementTreatment modalitiesComplete occlusionEmbolization Device